Graft-versus-host disease (GvHD)-induced apoptosis of the skin targets both epidermal keratinocytes, and dermal endothelial cells. We studied the donor-versusrecipient origin of GvHD of these target cells in skin of 18 sex mismatched HSCT recipients. Combining XY FISH and double immunostaining, and further 3D tissue Zstack analysis, we found keratinocytes and endothelial cells of donor origin, but only in patients with GvHD. Using TUNEL assay on sister sections, we found a correlation between the numbers of chimeric and apoptotic epidermal and endothelial cells.
Introduction
Keratinocyte apoptosis and inflammatory infiltrate are the hallmarks of acute cutaneous graft-versus-host disease (GvHD), but endothelial cell damage is also found in human 1 and experimental studies. In an animal model we demonstrated that endothelial cells in all organs are targets of GvHD 2 . In humans with acute GvHD we have found disruption of micro-vessel walls in gut biopsies 3 . Endothelial damage has also been demonstrated at the chronic phase of GVHD in the skin 4 .
Studies in animal models 5 , and in human hematopoietic stem cell transplant (HSCT) recipients, have shown that marrow stem cells could differentiate into other cell types than blood cells, particularly in oral mucosa 6 , digestive tract 7 , and liver 8 . A recent study demonstrated that human bone marrow contributes to vascular endothelium in the skin 9 . However, the donor-versus-recipient origin of endothelium as target in GvHD lesions has not been studied in humans, so far.
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Patients and methods
Eighteen female patients received an allogeneic, non T-cell depleted, marrow transplant from a male sibling donor. Three patients were transplanted for aplastic anemia and 15 for malignant disease, after a myeloablative conditioning regimen (irradiation-based 10 patients; chemotherapy alone in 8). All patients were full hematopoietic donor chimera, without relapse, at the time of biopsy. A skin rash led to biopsy and among the 18 patients, 13 had biopsy-confirmed pathological acute GvHD.
Pathological grade was grade 3 in 6 patients, grade 2 in 5, and grade 1 in 2. All patients were given steroids which were rapidly tapered in 5 patients in whom pathological diagnosis was not acute GvHD but suspected drug-induced rash.
Biopsies from female patients grafted with a female donor were considered as negative controls (n=10) and biopsies from male recipients grafted with a male donor as positive controls (n=8). No significant differences in terms of pathological-confirmed acute GvHD, diagnosis or conditioning regimen emerged when comparing these "controls" to cases under analysis. All patients gave their informed consent to this study according to the Institution's procedures. This study was approved by the 
and progressively decreased later. This discrepancy in decline of apoptotic counts between the two cell types might be linked to a more rapid clearing process of apoptotic cells in the endothelium than in the epidermis. When donor-derived cell counts were also studied according to the delay between HSCT and biopsy, a striking correspondence could be observed between levels of apoptotic and donor-derived cells, both for epidermal and endothelial cells, in early and late biopsies. In all but one patient, donor-derived endothelial cells were only found in the upper dermis ( Figure 2C ), when donor-derived keratinocytes were found in the epidermal basal layers. It has been recently shown that lymphocyte migration into skin in GvHD is promoted through a recognition system in the papillary dermal endothelium 11 . The preferential distribution of donor-derived cells in our cases suggests that these cells are present, not only when GvHD damage occurs, but also where this damage occurs. Sale and coworkers showed that keratinocytes stem cells in the tips of rete ridges are preferred targets in acute skin GvHD 12 . This has been confirmed both in humans and in experimental models [13] [14] [15] Experimentally, it has been demonstrated that bone marrow-derived cells contribute to epithelial engraftment during wound healing 17 . In this mouse model, the proliferation index of epidermal cells correlated with the number of donor-derived cells within the wound. An interesting point in our study was the distribution of donor-derived keratinocytes in the basal layers, and also in the upper epidermis ( Figure 1A ), in late biopsies (after day 60) (Figure 2C ). This suggests that donor-derived keratinocytes, when engrafted in areas of GvHD lesions, follow the kinetic of normal keratinocytes within the epidermis.
Our results suggest the participation of donor-derived cells in endothelial repair of GvHD induced lesions. Recent experimental studies 18 demonstrated a similar mechanism in vessel repair 3 to 5 days after brain and skin injuries. We did not characterize the cell at the origin of chimeric cells. Circulating endothelial cells have been found in HSCT recipients 19, 20 , but the chimeric cells could also derive from a bone marrow multipotent mesenchymal stem cell 21, 22 , from a trans-differentiated adult hemangioblast 23 , or from myeloid precursors 24 .
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